Bottom line
SWISX vs GSID: the short answer
SWISX (Schwab International Index Fund) and GSID (Goldman Sachs MarketBeta(R) International Equity ETF) share a meaningful slice of their top holdings — about 75% by weight.
SWISX is cheaper at 0.06% vs 0.2% — a difference of $14 a year per $10,000 invested.
Over one year, SWISX returned +31.6% vs +3.9% for GSID (reporting dates differ).
Updated Nov 19, 2026
SWISX vs GSID side by side
| SWISX | GSID | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Schwab | Goldman Sachs |
| Category | International Stock | International Stock |
| Expense ratio | 0.06% | 0.2% |
| Annual cost per $10k | $6 | $20 |
| 10-yr cost on $10k (prospectus) | $77 | $313 |
| Max front load | — | None |
| 12b-1 fee | — | 0% |
| 1-yr return | +31.6% | +3.9% |
| 5-yr return (annualized) | +9.0% | — |
| 10-yr return (annualized) | +8.3% | — |
| Best quarter | +18.2% | +17.1% |
| Worst quarter | −23.2% | −14.5% |
| Net assets (fund) | $13.6B | $1.0B |
| Number of holdings | 697 | 896 |
| Portfolio turnover | 1% | 3% |
| Returns as of | Dec 31, 2025 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | SWISX | GSID | Difference |
|---|---|---|---|
| 2024 | +3.5% | +3.9% | −0.4% |
| 2023 | +18.2% | +17.8% | +0.4% |
| 2022 | −14.3% | −14.5% | +0.3% |
| 2021 | +11.3% | +11.1% | +0.2% |
Source: Fund prospectus bar charts
Holdings overlap
19 of SWISX's top 25 holdings also appear in GSID's top 25.
| Holding | SWISX | GSID |
|---|---|---|
| ASML Holding NV | 2.58% | 2.75% |
| Roche Holding AG | 1.48% | 1.32% |
| HSBC Holdings PLC | 1.41% | 1.44% |
| AstraZeneca PLC | 1.34% | 1.25% |
| Novartis AG | 1.30% | 1.22% |
| Siemens AG | 1.06% | 1.01% |
| Shell PLC | 1.03% | 1.05% |
| Toyota Motor Corp | 0.99% | 0.90% |
| Sap Se | 0.96% | 0.83% |
| Mitsubishi UFJ Financial Group Inc | 0.96% | 0.95% |
| Novo Nordisk A/S | 0.89% | 0.64% |
| Banco Santander SA | 0.88% | 0.81% |
| BHP Group Ltd | 0.81% | 1.00% |
| Commonwealth Bank of Australia | 0.80% | 0.89% |
| Allianz SE | 0.79% | 0.76% |
Source: SEC Form N-PORT
SWISX top 10
- ASML Holding NV — 2.58%
- Roche Holding AG — 1.48%
- HSBC Holdings PLC — 1.41%
- AstraZeneca PLC — 1.34%
- Novartis AG — 1.30%
- Nestle SA — 1.14%
- Siemens AG — 1.06%
- Shell PLC — 1.03%
- Toyota Motor Corp — 0.99%
- Sap Se — 0.96%
GSID top 10
- Asml Holding Nv — 2.75%
- Goldman Sachs Financial Square Funds Prime Obligations Fund — 1.48%
- Hsbc Holdings Plc — 1.44%
- Roche Holding Ag — 1.32%
- Astrazeneca Plc — 1.25%
- Novartis Ag — 1.22%
- Nestle' Sa/ag — 1.17%
- Shell Plc — 1.05%
- Goldman Sachs Trust — 1.03%
- Siemens Ag — 1.01%
FAQ
What is the difference between SWISX and GSID?
Which is cheaper, SWISX or GSID?
Should I own both SWISX and GSID?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.